Cargando…

Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas: Erratum

Detalles Bibliográficos
Autores principales:	Xiao, Zhengzheng, Yang, Xiaoli, Zhang, Kun, Liu, Zebin, Shao, Zheng, Song, Chaojun, Wang, Xiaobin, Li, Zhengwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149644/ https://www.ncbi.nlm.nih.gov/pubmed/35693748 http://dx.doi.org/10.7150/ijms.71659

Ejemplares similares

Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas
por: Xiao, Zhengzheng, et al.
Publicado: (2020)

Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the STAT5/cyclin D1 and STAT5/Bcl-xL signaling pathways
por: Xiao, Zhengzheng, et al.
Publicado: (2021)

Association of prolactin receptor (PRLR) variants with prolactinomas
por: Gorvin, Caroline M, et al.
Publicado: (2019)

Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas.
por: Missale, C., et al.
Publicado: (1995)

Is prolactin receptor signaling a target in dopamine-resistant prolactinomas?
por: Ferraris, Jimena
Publicado: (2023)

Bromocriptine Therapy for the Treatment of Invasive Prolactinoma: The Single Institute Experience
por: Cho, Kyung Rae, et al.
Publicado: (2013)

GASC1 promotes glioma progression by enhancing NOTCH1 signaling
por: Xiao, Zhengzheng, et al.
Publicado: (2021)

Erratum: G Protein-coupled Estrogen Receptor Protects from Atherosclerosis
por: Meyer, Matthias R., et al.
Publicado: (2015)

Temporal resolution of idiopathic granulomatous mastitis with resumption of bromocriptine therapy for prolactinoma
por: Bouton, Marcia E., et al.
Publicado: (2015)

Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma
por: Menon, Lakshmi P., et al.
Publicado: (2021)

Erratum to: Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status
por: Malkov, Serghei, et al.
Publicado: (2017)

Successful management of octreotide-insensitive thyrotropin-secreting pituitary adenoma with bromocriptine and surgery: A case report and literature review: Erratum
Publicado: (2017)

Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells
por: Huang, Jinxiang, et al.
Publicado: (2017)

Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach
por: Dekker, T. J. A., et al.
Publicado: (2015)

Erratum: “Hydroxylated Polybrominated Biphenyl Ethers Exert Estrogenic Effects via Nongenomic G Protein–Coupled Estrogen Receptor Mediated Pathways”
por: Cao, Lin-Ying, et al.
Publicado: (2018)

Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes
por: Oshige, Tamami, et al.
Publicado: (2019)

Impact of Nano-Bromocriptine on Egg Production Performance and Prolactin Expression in Layers
por: Dawod, Ahmed, et al.
Publicado: (2021)

Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy
por: Yuan, Hongyan, et al.
Publicado: (2018)

Effect of prolactin and bromocriptine on growth of transplanted hormone-dependent mouse mammary tumours.
por: Briand, P., et al.
Publicado: (1977)

Bromocriptine or cabergoline-induced cerebrospinal fluid rhinorrhea: A life-threatening complication during management of prolactinoma
por: Singh, Pratibha, et al.
Publicado: (2011)

Rapid and dramatic glucose‐lowering effect of bromocriptine in an inadequately controlled type 2 diabetes patient with prolactinoma
por: Igata, Motoyuki, et al.
Publicado: (2020)

Erratum to: Association of environmental chemicals & estrogen metabolites in children
por: Ihde, Erin Speiser, et al.
Publicado: (2016)

The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer : Erratum
por: Xu, Wei, et al.
Publicado: (2021)

Metformin inhibits growth and prolactin secretion of pituitary prolactinoma cells and xenografts
por: Gao, Jun, et al.
Publicado: (2018)

Discordance Between Prolactinoma Size and Prolactin Level: An Unusual Laboratory Finding
por: Dawaher, Wafa, et al.
Publicado: (2021)

Postmenopausal vaginal atrophy: evaluation of treatment with local estrogen therapy [Erratum]
Publicado: (2014)

Erratum to: “The Relationship Between Bone and Reproductive Hormones Beyond Estrogens and Androgens”
Publicado: (2021)

Erratum to “New Insights into Ligand-Receptor Pairing and Coevolution of Relaxin Family Peptides and Their Receptors in Teleosts”
por: Good, Sara, et al.
Publicado: (2013)

Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells
por: Kavarthapu, Raghuveer, et al.
Publicado: (2016)

Essential role of endogenous prolactin and CDK7 in estrogen-induced upregulation of the prolactin receptor in breast cancer cells
por: Kavarthapu, Raghuveer, et al.
Publicado: (2017)

Erratum: Toll-like receptor ligands sensitize B-cell receptor signalling by reducing actin-dependent spatial confinement of the receptor
por: Freeman, Spencer A., et al.
Publicado: (2015)

Erratum to “The Role of Neurokinin-1 Receptor in the Microenvironment of Inflammation and Cancer”
por: Rosso, Marisa
Publicado: (2012)

ERRATUM: Estrogen oversees the maintenance of the female genetic program in terminally differentiated gonochorists
por: Paul-Prasanth, B., et al.
Publicado: (2014)

Erratum: Unraveling novel TF-miRNA regulatory crosstalk in metastasis of Soft Tissue Sarcoma
por: Samantarrai, Devyani, et al.
Publicado: (2015)

Bromocriptine and cabergoline induce cell death in prolactinoma cells via the ERK/EGR1 and AKT/mTOR pathway respectively
por: Tang, Chao, et al.
Publicado: (2019)

Erratum: Effects of low dose estrogen therapy on the vaginal microbiomes of women with atrophic vaginitis
por: Shen, Jian, et al.
Publicado: (2016)

Erratum to: The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer
por: Crane, Lucia M. A., et al.
Publicado: (2012)

Erratum to: Metabotropic glutamate receptor 5 may be involved in macrophage plasticity
por: Shanshiashvili, Lali, et al.
Publicado: (2017)

SUN-289 Symptomatic Prolactinoma with Modestly Elevated Prolactin Levels: A Cautionary Tale
por: Raisingani, Manish
Publicado: (2019)

Erratum: Pathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3
por: Chen, Wei-Sheng, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_20183udlalco2cqn5t53u5scc7